Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kalvista Pharmaceuticals LtdfiledCriticalKalvista Pharmaceuticals Ltd
Publication of AR123802A1publicationCriticalpatent/AR123802A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Reivindicación 2: El compuesto de fórmula (A) (o una sal y/o solvato farmacéuticamente aceptable de este) para uso en un método para el tratamiento profiláctico de un angioedema mediado por bradicinina que comprende: la administración oral de un compuesto fórmula A (o una sal y/o solvato farmacéuticamente aceptable de este) a un paciente que lo necesita, caracterizado porque el compuesto de fórmula A es, como se muestra a continuación.Claim 2: The compound of formula (A) (or a pharmaceutically acceptable salt and/or solvate thereof) for use in a method for the prophylactic treatment of bradykinin-mediated angioedema comprising: oral administration of a compound formula A ( or a pharmaceutically acceptable salt and/or solvate thereof) to a patient in need thereof, characterized in that the compound of formula A is, as shown below.